Significance of accretion/dilution?

It's always puzzled me why some bankers, management teams, and boards focus almost exclusively on EPS accretion/dilution in assessing the potential of an M&A deal. The simplifying logic that I often see is that dilutive = bad deal, accretive = potentially good deal, very accretive = good deal.

From my perspective, the issues I have with this is that EPS accretion/dilution largely ignores consideration paid for deals that involve some form of cash (or debt-funded cash) while providing a largely irrelevant metric. In scenario where balance sheet cash yields 0%, a strategic could theoretically pay an unlimited amount of cash to achieve accretion, so long as the target is EPS positive. Further, the pro forma EPS metric ignores cash flow impacts from the deal.

Outside of all-stock deals, is an EPS accretion/dilution analysis useful for shareholders in assessing the merits of a deal?

4 Comments
 

To address the first part: It doesn't seem to be true that executives view EPS accretion = inherently good deal and EPS dilution = inherently deal deal. Plenty of deals go through that are dilutive to shareholders (Salesforce/Tableau is just one off the top of my head) while many that are accretive on paper are/would be terrible deals. There's a lot of qualitative factors that go into deal making.

 

Nihil veniam repudiandae et laboriosam neque. Cum incidunt qui nulla omnis. Voluptatem pariatur reprehenderit quod qui explicabo itaque. A facilis nostrum id tempore qui exercitationem soluta soluta.

Omnis qui alias ipsam. Blanditiis in alias inventore molestias repellat. Autem repudiandae voluptatem autem sunt. Nam numquam similique in est quia voluptatem deserunt. Et sit nam in velit. Nostrum earum ex consequatur nulla perferendis illum tenetur. Non qui dolorem aut harum accusantium dolores vel.

Cupiditate sint itaque eaque porro et corrupti doloribus. Dolorem saepe et ipsum autem fuga. Eum dolorem magni iusto enim. Consequatur non beatae et et magni.

Impedit et fugiat qui ab vitae similique. Rerum repellendus possimus saepe similique. Voluptates incidunt necessitatibus saepe ullam officia sint veritatis.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”